Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China.
Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Chem Biol Drug Des. 2018 Jan;91(1):50-61. doi: 10.1111/cbdd.13055. Epub 2017 Jul 19.
Amphibian skin secretions are known to contain numerous peptides with a large array of biological activities. Bombinins are a group of amphibian-derived peptides with broad spectrum antimicrobial activities that have been only identified from the ancient toad species, Bombina. In this study, we described the identification and characterization of a novel bombinin precursor which encoded a bombinin-like peptide (BLP-7) and a novel bombinin H-type peptide (named as Bombinin H-BO) from the skin secretion of Oriental fire-bellied toad, Bombina orientalis. The primary structures of both mature peptides were determined by combinations of molecular cloning of peptide precursor-encoding cDNAs and mass spectrometry techniques. Secondary structure prediction revealed that both peptides had cationic amphipathic α-helical structural features. The synthetic replicate of BLP-7 displayed more potent antimicrobial activity than Bombinin H-BO against Gram-positive and Gram-negative bacteria and yeast. Also, in vitro antitumour assay showed that both peptides possessed obvious antiproliferative activity on three human hepatoma cells (Hep G2/SK-HEP-1/Huh7) at the non-toxic doses. These results indicate the peptide family of bombinins could be a potential source of drug candidates for anti-infection and anticancer therapy.
两栖动物皮肤分泌物中已知含有许多具有广泛生物活性的肽。蛙皮素是一组具有广谱抗菌活性的两栖动物衍生肽,仅从古老的蟾蜍物种(如中华蟾蜍)中鉴定出来。在这项研究中,我们描述了一种新型蛙皮素前体的鉴定和特征,该前体编码了一种蛙皮素样肽(BLP-7)和一种新型蛙皮素 H 型肽(命名为 Bombinin H-BO),它们来自东方火腹蟾蜍(Bombina orientalis)的皮肤分泌物。通过对编码前体的 cDNA 的分子克隆和质谱技术的组合,确定了这两种成熟肽的一级结构。二级结构预测表明,这两种肽都具有阳离子两亲性α-螺旋结构特征。BLP-7 的合成副本显示出比 Bombinin H-BO 更强的抗革兰氏阳性和革兰氏阴性细菌和酵母的抗菌活性。此外,体外抗肿瘤试验表明,两种肽在非毒性剂量下对三种人肝癌细胞(Hep G2/SK-HEP-1/Huh7)均具有明显的增殖抑制活性。这些结果表明,蛙皮素肽家族可能是抗感染和抗癌治疗药物候选物的潜在来源。